Toxicity and cosmetic outcome after hypofractionated whole breast irradiation and boost-IOERT in early stage breast cancer (HIOB): First results of a prospective multicenter trial (NCT01343459).
Fastner G, Reitsamer R, Urbański B, Kopp P, Murawa D, Adamczyk B, Karzcewska A, Milecki P, Hager E, Reiland J, Ciabattoni A, Matuschek C, Budach W, Nowell K, Schumacher C, Ricke A, Fusco V, Vidali C, Alessandro M, Ivaldi GB, Ziegler I, Fussl C, Zehentmayr F, Grambozov B, Sir A, Hitzl W, Ricardi U, Sedlmayer F.
Fastner G, et al. Among authors: hager e.
Radiother Oncol. 2020 May;146:136-142. doi: 10.1016/j.radonc.2020.02.001. Epub 2020 Mar 6.
Radiother Oncol. 2020.
PMID: 32151790
Clinical Trial.